10. Harbord R.M., Harris R.J., Sterne J.A.C. Updated tests for small-study effects in meta-analyses. Stata J. 2009; 9 (2): 197-210.
11. Palmer T.M., Peters J.L., Sutton A.J., Moreno S.G. Contour-enhanced funnel plots for meta-analysis. Stata J. 2008; 8 (2): 242-54.
12. Atallah A., Lecarpentier E., Goffinet F., Doret-Dion M., Gaucherand P., Tsatsaris V. Aspirin for prevention of preeclampsia. Drugs. 2017; 77 (17): 1819-31. Epub 2017 Oct 19. DOI: https://doi.org/10.1007/s40265-017-0823-0 PMID: 29039130; PubMed Central PMCID: PMC5681618.
13. Roberge S., Nicolaides K., Demers S., Hyett J., Chaillet N., Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol. 2017; 216 (2): 110-20.e6. Epub 2016 Sept 20. DOI: https://doi.org/10.1016/j.ajog.2016.09.076 PMID: 27640943.
14. Cui Y., Zhu B., Zheng F. Low-dose aspirin at <16 weeks of gestation for preventing preeclampsia and its maternal and neonatal adverse outcomes: a systematic review and meta-analysis. Exp Ther Med. 2018; 15: 4361-9. DOI: https://doi.org/10.3892/etm.2018.5972 PMID: 29725376.
15. Werner E.F., Hauspurg A.K., Rouse D.J. A cost-benefit analysis of low-dose aspirin prophylaxis for the prevention of preeclampsia in the United States. Obstet Gynecol. 2015; 126 (6): 1242-50. DOI: https://doi.org/10.1097/AOG.0000000000001115 PMID: 26551178.
16. Mirabito Colafella K.M., Neuman R.I., Visser W., Danser A.H.J., Versmissen J. Aspirin for the prevention and treatment of pre-eclampsia: a matter of COX-1 and/or COX-2 inhibition? Basic Clin Pharmacol Toxicol. 2020; 127 (2): 132-41. Epub 2019 Aug 20. DOI: https://doi.org/10.im/bcpt.13308 PMID: 31420920.
17. Ayala D.E., Ucieda R., Hermida R.C. Chronotherapy with low-dose aspirin for prevention of complications in pregnancy. Chronobiol Int. 2013; 30 (1-2): 260-79. DOI: https://doi.org/10.3109/07420528.2012.717 455 PMID: 23004922.
18. Beroyz G., Casale R., Farreiros A., Palermo M., Margulies M., Voto L. , et al. CLASP - a randomized trial of low-dose aspirin for the prevention and treatment of preeclampsia among 9364 pregnant-women. Lancet. 1994; 343 (8898): 619-29. PMID: 7906809
19. Byaruhanga R.N., Chipato T., Rusakaniko S. A randomized controlled trial of low-dose aspirin in women at risk from pre-eclampsia. Int J Gynecol Obstet. 1998; 60 (2): 129-35. DOI: https://doi.org/10.1016/s0020-7292(97)00257-9 PMID: 9509950.
20. Caspi E., Raziel A., Sherman D., Arieli S., Bukovski I., Weinraub Z. Prevention of pregnancy-induced hypertension in twins by early administration of low-dose aspirin - a preliminary report. Am J Reprod Immunol. 1994; 31 (1): 19-24. DOI: https://doi.org/10.111Vj.1600-0897.1994.tb00842.x PMID: 8166943.
21. Chiaffarino F., Parazzini F., Paladini D., Acaia B., Ossola W., Ma-rozio L., et al. A small randomised trial of low-dose aspirin in women at high risk of pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 2004; 112 (2): 142-4. DOI: https://doi.org/10.1016/s0301-2115(03)00269-0 PMID: 14746947.
22. Ebrashy A., Ibrahim M., Marzook A., Yousef D. Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial. Croat Med J. 2005; 46 (5): 826-31. PMID: 16158479.
23. ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. Br J Obstet Gynaecol. 1996; 103 (1): 39-47.
24. Gilani A., Khan Z. Role of aspirin in management of pregnancy induced hypertension. A study in Pakistani population. Specialist. 1994; 10 (4): 323-5.
25. Golding J., Forrester T., Jones D., McCaw-Binns A., Palmer-Levy M., Wilks R., et al. A randomised trial of low dose aspirin for primiparae in pregnancy. Br J Obstet Gynaecol. 1998; 105 (3): 293-9. DOI: https://doi.org/10.1111/j.1471-0528.1998.tb10089.x PMID: 9532989.
26. Haapsamo M., Martikainen H., Tinkanen H., Heinonen S., Nuojua-Huttunen S., Rasanen J. Low-dose aspirin therapy and hypertensive pregnancy complications in unselected IVF and ICSI patients: a randomized, placebo-controlled, double-blind study. Hum Reprod. 2010; 25 (12): 2972-7. DOI: https://doi.org/10.1093/humrep/deq286 PMID: 20943705.
27. Hauth J., Goldenberg R., Philips J., Copper R., DuBard M,. Cutter G. Low-dose aspirin therapy to prevent preeclampsia: safety considerations. Am J Obstet Gynecol. 1993; 168: 389.
28. Herabutya Y., Jetsawangsri T., Saropala N. The use of low-dose aspirin to prevent preeclampsia. Int J Gynaecol Obstet. 1996; 54 (2): 177-8. DOI: https://doi.org/10.1016/0020-7292(96)02701-4 PMID: 9236320.
29. Morris J.M., Fay R.A., Ellwood D.A., Cook C.M., Devonald K.J. A randomized controlled trial of aspirin in patients with abnormal uterine artery blood flow. Obstet Gynecol. 1996; 87 (1): 74-8. Epub 1996 Jan 1. DOI: https://doi.org/10.1016/0029-7844(95)00340-1 PMID: 8532271.
30. Odibo A.O., Goetzinger K.R., Odibo L., Tuuli M.G. Early prediction and aspirin for prevention of pre-eclampsia (EPAPP) study: a randomized controlled trial. Ultrasound Obstet Gynecol. 2015; 46 (4): 414-8. DOI: https://doi.org/10.1002/uog.14889 PMID: 25914193.
31. Parazzini F. , Benedetto C., Frusca T., Gregorini G., Bocciolone L., Marozio L., et al. Low-dose aspirin in prevention and treatment of intrauterine growth-retardation and pregnancy-induced hypertension. Lancet. 1993; 341 (8842): 396-400. PMID: 8094168
32. Rolnik D.L., Wright D., Poon L.C.Y., Syngelaki A., O'Gorman N., de Paco Matallana C., et al. ASPRE trial: performance of screening for preterm preeclampsia. Ultrasound Obstet Gynecol. 2017; 50 (4): 492-5. Epub 2017 Jul 26. DOI: https://doi.org/10.1002/uog.18816 PMID: 28741785.
33. Rotchell Y.E . , Cruickshank J.K., Gay M.P., Griffiths J., Stewart A., Farrell B., et al. Barbados low dose aspirin study in pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications. Br J Obstet Gynaecol. 1998; 105 (3): 286-92. DOI: https://doi.org/10.1111/j.1471-0528.1998.tb10088.x PMID: 9532988.
34. Subtil D., Goeusse P., Puech F., Lequien P., Biausque S., Breart G., et al. Aspirin (100 mg) used for prevention of pre-eclampsia in nullipa-rous women: the Essai Regional Aspirine Mere-Enfant study (part 1). BJOG. 2003; 110: 475-84.
35. Talari H., Mesdaghinia E., Abedzadeh Kalahroudi M. Aspirin and preeclampsia prevention in patients with abnormal uterine artery blood flow. Iran Red Crescent Med J. 2014; 16 (8): e17175. DOI: https://doi.org/10.5812/ircmj.17175 PMID: 25389483; PMCID: PMC4222009.
36. Tewari S., Kaushish R., Sharma S., Gulati N. Role of low dose aspirin in prevention of pregnancy induced hypertension. J Indian Med Assoc. 1997; 95 (2): 43-4. PMID: 9357241.
37. Vainio M., Kujansuu E., Iso-Mustajarvi M., Maenpaa J. Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches. BJOG. 2002; 109 (2): 161-7. DOI: https://doi.org/10.1111/j.1471-0528.2002.01046.x PMID: 11888098.
38. Viinikka L., Hartikainen-Sorri A.L., Lumme R., Hiilesmaa V., Ylikorkala O. Low dose aspirin in hypertensive pregnant women: effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn. Br J Obstet Gynaecol. 1993; 100 (9): 809-15. DOIL https://doi.org/10.1111/j.1471-0528.1993.tb14304.x PMID: 8217999.
39. Villa P.M., Kajantie E., Raikkonen K., Pesonen A.K., Hamalainen E., Vainio M., et al. Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials. BJOG. 2013; 120 (1): 64 - 74. DOI: https://doi.org/10.1111/j.1471-0528.2012.03493.x PMID: 23126307.